News - Defined Health, now known as Cello Health BioConsulting - Cello Health BioConsulting delivers a fusion of expertise to unlock the potential of organisations, brands and assets

menu

Nanobiotix presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical Oncology Gastrointestinal Annual Meeting

Nanobiotix presents first promising data from Phase I/II Liver Cancers trial of NBTXR3 at the American Society Of Clinical Oncology Gastrointestinal Annual Meeting

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting

Boehringer, Dicerna pen $201M pact to hit NASH with RNAi

Boehringer, Dicerna pen $201M pact to hit NASH with RNAi

Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer

Amgen-partnered Immatics bags a $58M round to fund its first clinical steps on new T-cell tech for cancer

Medicines Co scores FDA OK for new antibiotic, now up on the auction block

Medicines Co scores FDA OK for new antibiotic, now up on the auction block

FDA ushers in a new era in cancer treatment with ‘historic’ CAR-T approval for Novartis

FDA ushers in a new era in cancer treatment with ‘historic’ CAR-T approval for Novartis

MorphoSys Celebrates 25th Anniversary

MorphoSys Celebrates 25th Anniversary

Nanobiotix Announces First Positive Human Data Showing That Nbtxr3 Could Become A Backbone In Immuno-Oncology

Nanobiotix Announces First Positive Human Data Showing That Nbtxr3 Could Become A Backbone In Immuno-Oncology

Heptares to Receive US$5 Million Milestone Payment from Teva

Heptares to Receive US$5 Million Milestone Payment from Teva

Heptares Co-founder and CSO, Fiona Marshall, Receives 2017 John Daly Lecture Award in Recognition of her Outstanding Contribution to GPCR Drug Discovery

Heptares Co-founder and CSO, Fiona Marshall, Receives 2017 John Daly Lecture Award in Recognition of her Outstanding Contribution to GPCR Drug Discovery